These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28179196)

  • 21. Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs.
    Hashimoto Y; Shimizu T; Mima Y; Abu Lila AS; Ishida T; Kiwada H
    Toxicol Appl Pharmacol; 2014 May; 277(1):30-8. PubMed ID: 24632081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
    Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
    Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production.
    Tagami T; Nakamura K; Shimizu T; Ishida T; Kiwada H
    J Control Release; 2009 Aug; 137(3):234-40. PubMed ID: 19361546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection.
    Xu H; Ye F; Hu M; Yin P; Zhang W; Li Y; Yu X; Deng Y
    Drug Deliv; 2015; 22(5):598-607. PubMed ID: 24524364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F; Ye X; Wu Y; Wang H; Sheng C; Peng D; Chen W
    J Pharm Sci; 2019 Jan; 108(1):641-651. PubMed ID: 30595169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes.
    Shimizu T; Lila ASA; Kitayama Y; Abe R; Takata H; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2024; 47(2):469-477. PubMed ID: 38383000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomes.
    Grad P; Gedda L; Edwards K
    J Colloid Interface Sci; 2020 Oct; 578():281-289. PubMed ID: 32531558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice.
    Elsadek NE; Lila ASA; Emam SE; Shimizu T; Takata H; Ando H; Ishima Y; Ishida T
    Eur J Pharm Biopharm; 2020 Jul; 152():56-62. PubMed ID: 32376372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
    Ishida T; Ichihara M; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):243-50. PubMed ID: 17011060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
    Ishida T; Kiwada H
    Yakugaku Zasshi; 2008 Feb; 128(2):233-43. PubMed ID: 18239370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice.
    Gaballa SA; Shimizu T; Takata H; Ando H; Ibrahim M; Emam SE; Amorim Matsuo NC; Kim Y; Naguib YW; Mady FM; Khaled KA; Ishida T
    Mol Pharm; 2024 Feb; 21(2):622-632. PubMed ID: 38273445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.
    Tagami T; Nakamura K; Shimizu T; Yamazaki N; Ishida T; Kiwada H
    J Control Release; 2010 Mar; 142(2):160-6. PubMed ID: 19850094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance.
    Kaminskas LM; McLeod VM; Porter CJ; Boyd BJ
    J Pharm Sci; 2011 Nov; 100(11):5069-77. PubMed ID: 21721002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-PEG IgM Production via a PEGylated Nanocarrier System for Nucleic Acid Delivery.
    Abu Lila AS; Ishida T
    Methods Mol Biol; 2019; 1943():333-346. PubMed ID: 30838627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes.
    El Sayed MM; Shimizu T; Abu Lila AS; Elsadek NE; Emam SE; Alaaeldin E; Kamal A; Sarhan HA; Ando H; Ishima Y; Ishida T
    Int J Pharm; 2022 Mar; 615():121539. PubMed ID: 35124114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route.
    Takata H; Shimizu T; Yamade R; Elsadek NE; Emam SE; Ando H; Ishima Y; Ishida T
    J Control Release; 2023 Aug; 360():285-292. PubMed ID: 37355210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS; Uehara Y; Ishida T; Kiwada H
    J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of PEGylated liposome-associated proteins relating to the accelerated blood clearance phenomenon by combination with shotgun analysis and conventional methods.
    Kawanishi M; Hashimoto Y; Shimizu T; Sagawa I; Ishida T; Kiwada H
    Biotechnol Appl Biochem; 2015; 62(4):547-55. PubMed ID: 25196743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.
    Shiraishi K; Hamano M; Ma H; Kawano K; Maitani Y; Aoshi T; Ishii KJ; Yokoyama M
    J Control Release; 2013 Feb; 165(3):183-90. PubMed ID: 23220106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 354(1-2):56-62. PubMed ID: 18083313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.